Zhu et al. found that AACT acts as a tumor suppressor in liver cancer and inhibits the PI3K/AKT/mTOR pathway by activating PTEN, thus inhibiting the development and metastasis of liver cancer. This evidence concerns the gene PTEN and liver cancer.